Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising demand for diagnostic testing
3.2.1.2 Growing technological advancement in blood collection
3.2.1.3 Rising prevalence of chronic diseases
3.2.1.4 Growing adoption of point-of-care testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of serum separation gel tubes
3.2.2.2 Compliance with regulatory requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Serum separation gel without integrated tubes
5.3 Serum separation gel with integrated tubes
Chapter 6 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Blood banks
6.4 Pharmaceutical companies
6.5 Other end-users
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Becton, Dickinson and Company
8.2 BIOSIGMA S.p.A.
8.3 Bio-Rad Laboratories, Inc.
8.4 Cardinal Health, Inc.
8.5 Danaher Corporation
8.6 FL MEDICAL s.r.l.
8.7 Greiner AG
8.8 InterVacTechnology
8.9 Qiagen N.V.
8.10 Sekisui Chemical CO., LTD.
